Captive-bred rhesus macaques of Indian origin represent one of the most important large animal models for infectious disease, solid organ transplantation, and stem cell research. There is a dearth of information defining hematopoietic development, including neutrophil leukocyte differentiation in this species using multicolor flow cytometry. In the current study, we sought to identify cell surface markers that delineate neutrophil progenitor populations with characteristic immunophenotypes. We defined four different postmitotic populations based on their CD11b and CD87 expression pattern, and further refined their immunophenotypes using CD32, CD64, lactoferrin, and myeloperoxidase as antigenic markers. The four subsets contained myelocyte, metamyelocyte, band, and segmented neutrophil populations. We compared our flow cytometrybased classification with the classical nuclear morphology-based classification. We found overlap of immunological phenotype between populations of different nuclear morphology and identified phenotypically different subsets within populations of similar nuclear morphology. We assessed the responsiveness of these populations to stimulatory signals, such as LPS, fMLP, or PMA, and demonstrated significant differences between human and rhesus macaque neutrophil progenitors. In this study, we provided evidence for species-specific features of granulopoiesis that ultimately manifested in the divergent immunophenotypes of the fully differentiated segmented neutrophils of humans and rhesus macaques. Additionally, we found functional markers that can be used to accurately quantify neutrophil progenitors by flow cytometry. Although these markers do not coincide with the classical nuclear-morphology-based grading, they enable us to perform functional studies monitoring immunophenotypic markers.
INTRODUCTION
Neutrophil leukocytes are the most abundant WBCs in circulation. They represent first responders in any type of injury or inflammation. 1, 2 Mature neutrophils are nondividing cells with a lifespan of several days. 3, 4 Therefore, their homeostasis requires continuous replenishment supported by an uninterrupted differentiation process in the bone marrow. Differentiation stages of human neutrophil progenitor cell populations are distinguished according to their nuclear morphology. In successive order, these are myeloblasts, promyelocytes, myelocytes, metamyelocytes, bands, and segmented neutrophils. 5 Accurate quantitation of these cell populations with Abbreviations: APC, allophycocyanin; BV, brilliant violet; CR, complement receptor; IR ARD, infrared amino reactive dye; MPO, myeloperoxidase; PFA, paraformaldehyde Wright-Giemsa staining and microscopy is time consuming, inefficient, lacks any information about their functional capabilities, phenotypic heterogeneity, and provides no insights regarding through what steps neutrophil differentiation happens. 6 Quantitation using flow cytometry-based methods might offer significant improvement provided that appropriate differentiation markers are identified. 7, 8 In the case of human neutrophil progenitors, these critical differentiating markers have been the CD11b (complement receptor [CR] 3), CD15
(Lewis-x), CD16 (FcR III), CD33, and the CD49d (VLA-4) Ags. 7, 9 Although the primary benefit of using nonhuman primates in biomedical research is the similarity of their immune system to the human immune system, numerous species-specific differences exist that can affect study designs and outcomes. [10] [11] [12] [13] [14] [15] For example, circulating neutrophil leukocytes in humans express both low affinity immunoglobulin Fc receptors (Fc R II and III) CD32 and CD16. 16 Neutrophils of several nonhuman primate species including rhesus macaques, cynomolgus macaques, African green monkeys, and baboons do not express CD16 (17, our unpublished data). However, the absence of CD16 on nonhuman primate neutrophils cannot be generalized because sooty mangabeys do express this receptor on their polymorphonuclear neutrophilic granulocyte. 17 In the current study we sought to establish a flow cytometric protocol with differentiation markers that unequivocally define distinct subsets, and provide a tool to accurately quantitate neutrophil progenitors in the bone marrow of rhesus macaques. We compared our panel of markers between healthy adult human and rhesus samples to determine similarity and species-specific differences.
MATERIALS AND METHODS

Human bone marrow and blood samples
We purchased de-identified, freshly obtained human bone marrow and matching blood samples from 18-65 years old healthy individuals from AllCells LLC (Boston, MA) or Lonza Inc. (Mapleton, IL). The donors signed a procedure-specific consent form. Pregnant women were not included in the study.
Animals
We used freshly obtained whole blood and bone marrow from 1.5-9 years old healthy Indian rhesus macaques (Macaca mulatta). The animals in this study were assigned to various protocols approved by the University of Wisconsin Institutional Animal Care and Use Committee.
They were cared for according to the NIH "Guide to the Care and Use of Laboratory Animals."
Flow cytometric staining, data acquisition, and analysis
We dispersed the bone marrow cells in RPMI containing 10% FCS, and filtered them through a 100 m cell strainer. We stained 10 6 cells in 100 l tissue culture medium or 100 l EDTA anticoagulated whole blood at room temperature with CD3 Alexa488 (clone SP34-2), HLA-DR FITC (clone L243), CD123 FITC (clone 7G3), CD66a-e PerCP-Vio700 (clone TET2, Miltenyi, Auburn, CA), CD11b PE-Cy7 
Cell sorting
Identification of neutrophil maturational stage
Neutrophil maturational stage was based on generally accepted criteria of nuclear shape for veterinary species. 18 Segmented nuclei contained 2 or more lobes connected by nuclear segments that were less than one-half the width of the widest lobe. Band nuclei were S-or U-shaped with parallel sides lacking distinct segmentation; any narrowing of the nucleus had to maintain a width greater than onehalf the width of the thickest part of the nucleus. Metamyelocyte nuclei were elongate ovals with an indentation (reniform). Myelocyte nuclei were round or oval without an indentation. Percentages of each maturational stage and leukocyte type were based on 300 cell differential counts.
In vitro stimulation assays
Briefly, 100 l whole blood or 10 6 freshly processed bone marrow cells 
Statistical analysis
For statistical analysis, we employed Students' paired t test using Microsoft Excel software version 16.16.1 for Macintosh.
RESULTS AND DISCUSSION
Our goal was to establish a flow cytometric method for the quantification of neutrophil progenitor populations in the bone marrow of rhesus macaques. To that end, we had to find immunologic markers that defined separate differentiation stages reproducibly and unequivocally. We designed a multicolor flow cytometry panel selecting the CD11b, CD32, CD64, CD87, lactoferrin, and MPO Ags due to their established timeline in human neutrophil maturation. 4 CD11b mediates complement-coated pathogen uptake and regulates leukocyte adhesion as part of the CD11b/CD18 heterodimer. 19, 20 In humans, the absence of CD11b separates myeloblasts and promyelocytes from later neutrophil progenitor populations, as this Ag first appears at the myelocyte stage. 21 The low affinity immunoglobulin receptor CD32 appears as early as the myeloblast stage in humans, and its expression increases in the segmented neutrophil stage. 8, 22 The high affinity immunoglobulin receptor CD64 expression is maintained at a very low level until it is entirely down-regulated at the band stage in humans. 8, 22, 23 CD87 (urokinase plasminogen activator receptor) has been described as a marker to identify the band and segmented neutrophil populations in human bone marrow. 24 MPO can be detected in the primary azurophilic granules from the promyelocyte phase to the fully matured segmented neutrophils. 7, [25] [26] [27] Lactoferrin, a multifunctional protein with antimicrobial activity, appears first in the secondary granules at the metamyelocyte stage of human granulopoiesis. 7, [28] [29] [30] As the initial step of our analysis, we excluded lymphocytes, basophil and eosinophil granulocytes, stem cells, macrophages, dead cells, and cell aggregates (SFig. 1). Then we used principal component analysis to 2 components to identify those markers that accounted for the most variance within the CD66a-e + CD23 − gate, and thus defined distinct cell subsets robustly (Fig. 1A) . CD87 (-0.66), CD32 (-0.59), and (Fig. 1C) . The relative frequency of the populations from I through IV were: 10.1 ± 7.6, 13.6 ± 7.3, 21.6 ± 7.5, and 49.4 ± 8.5% of the parent population, respectively (n = 5).
Next, we determined the expression patterns of MPO, lactoferrin, CD32, and CD64 in these populations. MPO and lactoferrin were present in all 4 populations. While the MPO content/cell decreased, the intracellular level of lactoferrin increased in the consecutive populations (Table 1) . We detected CD64 on the cell surface at the CD11b + CD87 − phase (population II), and cells remained positive for this protein throughout the final stages of granulopoiesis ( Fig. 2D-F ). Thus, emergence of CD64 coincided with the appearance of CD11b, but preceded CD87 expression. On the other hand, CD32 first appeared in population III ( Fig. 1D and E) with increased expression in population IV (Fig. 2C-F , Table 1 ). To summarize the data above, we can refine the immunophenotype of the 4 populations as follows:
Immunophenotype of the neutrophil leukocytes in the peripheral blood shared the characteristics of population IV ( Fig. 2F and G, Table 1 ).
In humans, CD11b can be detected at the myelocyte stage first, 21 and the appearance of CD87 on the cell surface indicates the final steps (bands and segmented neutrophils) of maturation. 24 However, the expression pattern of CD11b and CD87 Ags together on neutrophil progenitors has not been published. To validate our staining panel for rhesus macaques, we stained human bone marrow samples.
While we found similarities between the two species, we also identified one major difference originating from three different levels of CD11b expression. In human samples, CD87 and CD11b defined five separate sub-populations that we designated, I, II, III, IIIa, and IV (Fig. 2H) . The phenotype of these populations can be defined as (Fig. 2I-M Numbers are the average of Geometric Mean of Fluorescence Intensity ± SD (n = 5), *P < 0.05, **P < 0.005 difference from the previous population listed in the table
As the phenotype of >97% of the circulating neutrophils resembled the phenotype of population IV (Table 1 , Fig. 2B ), we proposed that population I represents the most immature, and population IV is the most mature subset. To confirm this hypothesis, we sorted the CD11b/CD87-defined subsets and determined their cellular composition by nuclear morphology-based staging. We found overlap between the morphologically identified stages and the flow cytometry-based immunophenotypic categorization. In rhesus, myelocytes and metamyelocytes represented the majority of population I:
30 ± 15 and 59 ± 8%, respectively with 5 ± 5% presence of each of the band and segmented neutrophils. Population II contained negligible numbers of myelocytes 1±1%, 18±8% metamyelocytes, 44 ± 22% band, and 37 ± 28% segmented neutrophils. Population III consisted of 2 ± 2% of metamyelocytes, 53 ± 23% band, and 44 ± 24% segmented neutrophils, whereas the overwhelming majority 92 ± 6% of population IV was segmented neutrophils with 8 ± 5% of bands ( Fig. 3A and C-F). These results indeed support our hypothesis that population I represents cells at the less mature stage and the differentiation pathway leads toward population IV. We quantitated the heterogeneity of the populations classified by their nuclear morphology (Fig. 3B) . We found that in rhesus, myelocytes display almost exclusively the population I phenotype (97 ± 4.5%), metamyelocytes are a combination of populations I and II (51.6 ± 32.9 and 49.9 ± 39.4%, respectively), bands are mainly a mix of populations II and III (39.4 ± 3.7 and 51.1 ± 9.0%, respectively), and the segmented neutrophils are a combination of III and IV (22.9 ± 5.5 and 63.8 ± 18%, respectively). A more complex picture emerges in humans (Fig. 3G-M) . Most myelocytes display either population I or II phenotype (34.3 ± 7.7 and 43.8 ± 1.8%, respectively). This is primarily due to the earlier expression of CD11b, compared to the differentiation in rhesus macaques. Interestingly, in mice, CD11b
and CD32 are expressed on the cell surface throughout the entire granulopoiesis. 31 Although metamyelocytes can be found in populations I, II, and IIIa (Fig. 3L) , the majority of them (63.5 ± 3%) display III phenotype (Fig. 3M) . and 67.8 ± 8.8%, respectively). The data summarized in Fig. 3 provide evidence that the induction of nuclear segmentation and the changes in these immunophenotypic markers are not strongly connected. It is important to emphasize here that while CD87 is expressed at the two terminal stages of neutrophil differentiation in rhesus, it is only found on 53.9 ± 3.1% of band, and 83 ± 7.5% (n = 3) of segmented neutrophils at detectable levels. (None of the myelocytes and less than 5% of the metamyelocytes [4.3 ± 3.5] are CD87 positive). Therefore, this marker alone cannot be used to quantitate all band and segmented neutrophils in the bone marrow of rhesus macaques.
Next, to assess the functional capabilities of each neutrophil progenitor population subset, we stimulated matching blood and bone marrow samples in vitro with either LPS, fMLP, or PMA. We monitored the level of CD11b expression (Fig. 4A-C) , and the release of lactoferrin and MPO to the cell surface (Fig. 4D-F) as indicators of activation. 32, 33 Interestingly, while PMA induced significant changes in the phenotype of populations II-IV, neither LPS nor fMLP elicited activation in these populations. We detected LPS-induced CD11b increases only in the blood-derived neutrophil population of rhesus macaques ( Fig. 4G and I ). In the human samples, however, we measured significant increase of CD11b expression and lactoferrinpositive cell frequency after LPS and PMA treatments in bone marrow populations III and IV, which matched changes in blood samples ( Fig. 4H and J) . We found no measurable response to LPS and fMLP in populations I, II, and IIIa. These data suggest that while the human neutrophil progenitors complete their entire maturation in the bone marrow, the situation in rhesus macaques could be different. 
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